GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enzychem Lifesciences Corp (XKRX:183490) » Definitions » Days Sales Outstanding

Enzychem Lifesciences (XKRX:183490) Days Sales Outstanding : 49.47 (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Enzychem Lifesciences Days Sales Outstanding?

Enzychem Lifesciences's average Accounts Receivable for the three months ended in Mar. 2024 was ₩12,059 Mil. Enzychem Lifesciences's Revenue for the three months ended in Mar. 2024 was ₩22,244 Mil. Hence, Enzychem Lifesciences's Days Sales Outstanding for the three months ended in Mar. 2024 was 49.47.

The historical rank and industry rank for Enzychem Lifesciences's Days Sales Outstanding or its related term are showing as below:

XKRX:183490' s Days Sales Outstanding Range Over the Past 10 Years
Min: 43.16   Med: 93.25   Max: 123.31
Current: 45.71

During the past 10 years, Enzychem Lifesciences's highest Days Sales Outstanding was 123.31. The lowest was 43.16. And the median was 93.25.

XKRX:183490's Days Sales Outstanding is ranked better than
74.85% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.84 vs XKRX:183490: 45.71

Enzychem Lifesciences's Days Sales Outstanding increased from Mar. 2023 (36.44) to Mar. 2024 (49.47).


Enzychem Lifesciences Days Sales Outstanding Historical Data

The historical data trend for Enzychem Lifesciences's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzychem Lifesciences Days Sales Outstanding Chart

Enzychem Lifesciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 94.17 90.86 74.60 79.23 43.16

Enzychem Lifesciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.44 38.26 49.65 48.45 49.47

Competitive Comparison of Enzychem Lifesciences's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Enzychem Lifesciences's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enzychem Lifesciences's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Enzychem Lifesciences's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Enzychem Lifesciences's Days Sales Outstanding falls into.



Enzychem Lifesciences Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Enzychem Lifesciences's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (6357.781 + 11625.325) / 2 ) / 76038.894*365
=8991.553 / 76038.894*365
=43.16

Enzychem Lifesciences's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (11625.325 + 12492.56) / 2 ) / 22244.352*365 / 4
=12058.9425 / 22244.352*365 / 4
=49.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Enzychem Lifesciences  (XKRX:183490) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Enzychem Lifesciences Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Enzychem Lifesciences's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Enzychem Lifesciences (XKRX:183490) Business Description

Traded in Other Exchanges
N/A
Address
27 Gangnamdae-ro Seocho-gu, 10th Floor, aT Center, Seoul, KOR, 135-280
Enzychem Lifesciences Corp develops and produces APIs and functional health foods. It manufactures veterinary medicine tablets, capsules, syrups, injections, ointments, solutions for the diagnosis and prevention of various diseases. The company is also developing drugs to treat chemotherapy-induced neutropenia, chemo-radiation therapy-induced oral mucositis, asthma, psoriasis, rheumatoid arthritis, and others.

Enzychem Lifesciences (XKRX:183490) Headlines

No Headlines